Welcome to our dedicated page for ESAB SEC filings (Ticker: ESAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The ESAB Corporation (NYSE: ESAB) SEC filings page on Stock Titan brings together the company’s U.S. regulatory disclosures, helping investors review how this focused industrial compounder reports its activities. ESAB is based in North Bethesda, Maryland and operates globally in heating equipment and welding-related manufacturing, serving customers in roughly 150 countries.
ESAB’s filings include current reports on Form 8-K, which cover topics such as quarterly earnings releases, material financing arrangements and governance changes. For example, ESAB has filed 8-Ks to furnish press releases reporting financial results for specific quarters, to disclose an Amended and Restated Credit Agreement that established new term loan and revolving credit facilities, and to announce the appointment of a new independent director and the planned retirement of a long-serving board member.
Investors can also use this page to access periodic reports referenced in ESAB’s communications, such as quarterly reports on Form 10-Q, which provide more detailed financial statements and management discussion. ESAB’s earnings releases point to these filings for reconciliations of GAAP to non-GAAP measures like adjusted net income, core adjusted net income, adjusted EBITDA, core adjusted EBITDA, organic sales, core organic sales and adjusted free cash flow.
Stock Titan enhances these filings with AI-powered summaries that highlight key points, including revenue trends, margin performance, non-GAAP adjustments, acquisition impacts and covenant details in financing agreements. Users can quickly see which filings relate to topics such as credit facilities, acquisition announcements, dividend-related disclosures or board changes, and then drill into the full SEC documents for deeper review. Real-time updates from EDGAR ensure that new ESAB filings, including future 10-Q, 10-K and 8-K reports, are reflected promptly with plain-language explanations.
T. Rowe Price Associates, Inc. reported beneficial ownership of 5,852,722 shares of ESAB CORP common stock, representing 9.6% of the class as of the event date. The firm has sole voting power over 5,670,668 shares and sole dispositive power over 5,852,692 shares, with no shared voting or dispositive power. The shares were acquired and are held in the ordinary course of business, and T. Rowe Price states they were not acquired to change or influence control of ESAB.
ESAB Corp Chief Financial Officer Kevin J. Johnson reported several equity transactions in ESAB common stock. On
To cover the related tax liability and exercise price, 5,645 shares were withheld by ESAB at a price of
ESAB Corporation filed a notice of proposed share sales under Rule 144. The person for whose account the securities are to be sold plans to sell 3,494 shares of ESAB common stock through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $470,362.63.
The shares relate to options granted on 02/25/2019 and acquired and paid in cash on 02/06/2026. ESAB had 60,710,966 shares of common stock outstanding as of the disclosure, which is a baseline figure, not the amount being sold.
ESAB Corporation shareholder Mitchell P. Rales filed Amendment No. 1 to his Schedule 13D, reporting beneficial ownership of 3,606,271 shares of common stock, representing about 5.9% of the 60,710,966 shares outstanding as of October 22, 2025.
The filing explains that ESAB agreed to acquire Eddyfi Holding Inc., and in connection with this, ESAB will issue 175,000 shares of 6.50% Series A Mandatory Convertible Preferred Stock with an aggregate liquidation preference of $175.0 million. Rales agreed to purchase $100.0 million of this preferred stock, funded with his working capital.
The preferred shares will be issued at a closing that is contingent on, and substantially concurrent with, the closing of the Eddyfi acquisition. Rales will be subject to a lock-up from February 2, 2026 through 90 days after closing and will receive customary registration rights for common stock issuable upon conversion of the preferred shares.
ESAB Corporation executive Olivier Biebuyck, President of Fab Tech, reported routine equity compensation activity. On February 2, 2026, 1,232 restricted stock units were converted into the same number of ESAB common shares as they vested.
To cover related tax obligations, 627 shares were withheld by ESAB at a price of $114.62 per share, with no shares sold by Biebuyck on the market. Following these transactions, he directly holds 14,954 shares of ESAB common stock.
ESAB Corporation agreed for its subsidiary to acquire all shares of Québec-based Eddyfi Holding Inc. and related entities for $1.45 billion in cash, subject to customary closing adjustments. After closing, Eddyfi and its subsidiaries will be wholly owned by ESAB’s purchasing subsidiary.
To help finance the deal, ESAB obtained a $1.0 billion 364‑day unsecured bridge loan commitment from JPMorgan Chase, which may be reduced by other financings completed before closing. The acquisition is expected to close in the middle of 2026, subject to regulatory approvals in multiple jurisdictions and other standard conditions.
ESAB also entered into private placements, agreeing to sell 175,000 shares of 6.50% Series A Mandatory Convertible Preferred Stock with an aggregate liquidation preference of $175.0 million (net proceeds about $171.5 million), including purchases by entities affiliated with Mitchell and Steven Rales, and 1,254,255 common shares for $142,985,070 (net proceeds about $140.1 million) at $114.00 per share.
ESAB Corp SVP and General Counsel Curtis E. Jewell reported an employee stock option exercise and related tax withholding. On January 26, 2026, he exercised options for 3,960 shares of common stock at $33.49 per share. ESAB withheld 2,512 shares at $120.475 per share to cover the exercise price and associated tax liability, and no shares were sold into the market for this purpose. After these transactions, Jewell directly owned 15,626 shares of ESAB common stock and indirectly held 354.75 shares through a 401(k) plan.
ESAB Corp director Martin Sebastien reported new equity awards. On January 1, 2026, he was granted 231 restricted stock units (RSUs), each representing a contingent right to receive one share of ESAB common stock. These RSUs vest in a single installment on January 1, 2027, meaning the shares are deliverable only if he remains eligible through that date.
On the same date, he was also granted 777 stock options to purchase ESAB common stock at an exercise price of $112.57 per share. The filing states that these options vested and became exercisable in full on the grant date. Following these transactions, Sebastien directly holds 231 RSUs and 777 stock options as reported derivative securities.
ESAB Corp director Martin Sebastien reported beneficial ownership of 595 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of ESAB common stock. These RSUs were granted to him in connection with consulting services previously provided to the company. The units will vest in three equal, annual installments beginning on October 1, 2026 and continuing through October 1, 2028, if the vesting conditions are met. The filing shows these RSUs are held directly.
ESAB Corp reported an equity transaction by its Chief Financial Officer on January 2, 2026. The filing shows that 986 restricted stock units (RSUs) were converted into an equal number of shares of ESAB common stock, reflecting the vesting of a prior equity award. In connection with this vesting, 537 shares of common stock were withheld by ESAB to cover the officer's tax liability at a price of $112.57 per share, and no shares were sold by the officer for this purpose.
After these transactions, the officer directly beneficially owned 26,404 shares of ESAB common stock. The RSU award referenced in the filing vests in three equal annual installments that began on January 2, 2025, with the remaining restricted stock units scheduled to vest on January 2, 2027.